Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
238
Total raised
£3.1B
disclosed amounts
This month
£7.8M
raised so far
The financing round was led by EQT Life Sciences alongside co-leads Advent Life Sciences and British Business Bank.
"This Series B financing marks a defining moment for Cyted as we continue to deepen our commitment to detecting esophageal diseases earlier. This investment will help us consolidate our leading position in the market by expanding our US presence and adding new life-saving innovations to our advanced diagnostics portfolio."
The Oxford spinout secured backing from a group of healthcare investors to scale its EchoGo heart disease detection technology.
"Hospitals already possess the data; they just lack the tools to unlock its full diagnostic potential."
The health tech company surpassed £500k on Crowdcube with backing from more than 100 investors.
"Reaching the £500,000 threshold is an exciting moment, one that reflects investor belief in our mission to make diabetes screening simpler, earlier, and more accessible. With healthcare systems under increasing pressure, innovations like GTT@home can reduce clinical burden while improving patient experience and outcomes."
AIPO Fund led the strategic investment to fund product development and US market entry.
"We’re entering a transformative period for Adtec Healthcare. This investment from AIPO Fund and SG Biomedical not only provides the capital we need to expand globally but also reflects shared confidence in our vision: to make Cold Plasma a globally recognised and adopted standard in infection control and wound care. We’re proud of what our team has built, and excited to move forward with strong, experienced partners by our side."
The funding round was supported by BGF, Parkwalk Advisors, DBW, and BBI to drive clinical and product development.
"This investment is a strong endorsement of our team, technology, and vision. The early clinical data from our temporary device has given us real momentum, and with this funding, we’re excited to advance our permanent pacing platform, an innovation that could redefine how heart failure is treated."
.png)
